AbbVie's new auto-injector pen was developed to be easy to use and to reduce the burden on patients when performing ...

Acknowledging the importance of machinery design in advancing industrial progress and performance, the A' Manufacturing and ...

AI-based clinical simulation systems can be a game-changer for the pharmaceutical industry. The ability to predict clinical ...

As the pharmaceutical sector endeavours to become more sustainable, we hear how digital twins – virtual replicas of systems ...

Like most people these days, I have been experimenting with various artificial intelligence (AI) tools this past year. It’s ...

at which I joined a panel to discuss synthetic biology's accelerating impact on pharma. From gene editing to cellular and gene therapies, AI therapeutics design to bespoke antibodies, there’s so ...

Part one of a two-part series that identifies current uses of AI in drug discovery and development and assesses whether AI ...

This high-quality ready-to-use (RTU) solution is designed to meet the rigorous standards and increasing requirements of the ...

The latest deal in AI drug discovery is a twist on the usual big pharma-startup collaboration model, with Insitro licensing technology and Lilly eligible for royalties.

Eli Lilly and insitro said the deals offers a “new paradigm” for collaborations between major pharmaceutical companies and ...

In the initial discovery of a drug, it can take cancer researchers up to two years to narrow down 10,000 molecules to find ...